65 related articles for article (PubMed ID: 14595263)
1. Expression of ErbB-3 and ErbB-4 protooncogene proteins in oral squamous cell carcinoma: a pilot study.
de Vicente JC; Esteban I; Germanà P; Germanà A; Vega JA
Med Oral; 2003; 8(5):374-81. PubMed ID: 14595263
[TBL] [Abstract][Full Text] [Related]
2. Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck.
Ibrahim SO; Vasstrand EN; Liavaag PG; Johannessen AC; Lillehaug JR
Anticancer Res; 1997; 17(6D):4539-46. PubMed ID: 9494565
[TBL] [Abstract][Full Text] [Related]
3. Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma.
Xia W; Lau YK; Zhang HZ; Liu AR; Li L; Kiyokawa N; Clayman GL; Katz RL; Hung MC
Clin Cancer Res; 1997 Jan; 3(1):3-9. PubMed ID: 9815530
[TBL] [Abstract][Full Text] [Related]
4. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas.
Yi ES; Harclerode D; Gondo M; Stephenson M; Brown RW; Younes M; Cagle PT
Mod Pathol; 1997 Feb; 10(2):142-8. PubMed ID: 9127320
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma.
Khan AJ; King BL; Smith BD; Smith GL; DiGiovanna MP; Carter D; Haffty BG
Clin Cancer Res; 2002 Feb; 8(2):540-8. PubMed ID: 11839675
[TBL] [Abstract][Full Text] [Related]
6. Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members.
Xia W; Lau YK; Zhang HZ; Xiao FY; Johnston DA; Liu AR; Li L; Katz RL; Hung MC
Clin Cancer Res; 1999 Dec; 5(12):4164-74. PubMed ID: 10632356
[TBL] [Abstract][Full Text] [Related]
7. Loss of 14-3-3 sigma protein expression and presence of human papillomavirus type 16 E6 in oral squamous cell carcinoma.
Bhawal UK; Sugiyama M; Nomura Y; Kuniyasu H; Tsukinoki K
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1055-9. PubMed ID: 18936350
[TBL] [Abstract][Full Text] [Related]
8. Differential ErbB receptor expression and intracellular signaling activity in lung adenocarcinomas and squamous cell carcinomas.
López-Malpartida AV; Ludeña MD; Varela G; García Pichel J
Lung Cancer; 2009 Jul; 65(1):25-33. PubMed ID: 19046792
[TBL] [Abstract][Full Text] [Related]
9. Characterization of ten newly-derived human head and neck squamous carcinoma cell lines with special reference to c-erbB proto-oncogene expression.
O-Charoenrat P; Rhys-Evans P; Eccles S
Anticancer Res; 2001; 21(3B):1953-63. PubMed ID: 11497283
[TBL] [Abstract][Full Text] [Related]
10. Expression of c-erbB receptors, MMPs and VEGF in squamous cell carcinoma of the head and neck.
Do NY; Lim SC; Im TS
Oncol Rep; 2004 Aug; 12(2):229-37. PubMed ID: 15254682
[TBL] [Abstract][Full Text] [Related]
11. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
12. Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients.
Bei R; Budillon A; Masuelli L; Cereda V; Vitolo D; Di Gennaro E; Ripavecchia V; Palumbo C; Ionna F; Losito S; Modesti A; Kraus MH; Muraro R
J Pathol; 2004 Nov; 204(3):317-25. PubMed ID: 15476268
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of p27 expression in carcinoma of the oral cavity and oropharynx.
Venkatesan TK; Kuropkat C; Caldarelli DD; Panje WR; Hutchinson JC; Chen S; Coon JS
Laryngoscope; 1999 Aug; 109(8):1329-33. PubMed ID: 10443844
[TBL] [Abstract][Full Text] [Related]
14. Expression of epiregulin, a novel epidermal growth factor ligand associated with prognosis in human oral squamous cell carcinomas.
Shigeishi H; Higashikawa K; Hiraoka M; Fujimoto S; Mitani Y; Ohta K; Takechi M; Kamata N
Oncol Rep; 2008 Jun; 19(6):1557-64. PubMed ID: 18497965
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor (EGFR) expression in childhood brain tumors.
Bodey B; Kaiser HE; Siegel SE
In Vivo; 2005; 19(5):931-41. PubMed ID: 16097449
[TBL] [Abstract][Full Text] [Related]
16. Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression.
Shiga K; Shiga C; Sasano H; Miyazaki S; Yamamoto T; Yamamoto M; Hayashi N; Nishihira T; Mori S
Anticancer Res; 1993; 13(5A):1293-301. PubMed ID: 7902061
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC
J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
[TBL] [Abstract][Full Text] [Related]
19. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
[TBL] [Abstract][Full Text] [Related]
20. Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma.
Sheu JJ; Hua CH; Wan L; Lin YJ; Lai MT; Tseng HC; Jinawath N; Tsai MH; Chang NW; Lin CF; Lin CC; Hsieh LJ; Wang TL; Shih IeM; Tsai FJ
Cancer Res; 2009 Mar; 69(6):2568-76. PubMed ID: 19276369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
